Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Endologix Reports Positive One-Year Results From the Ovation LUCY Study
News | Stent Grafts | July 16, 2018

July 16, 2018 — Endologix Inc. announced one-year results from the LUCY (Evaluation of FemaLes who are...

High Intensity Exercise in Teenagers Could Ward Off Heart Disease

Ultrasound image of the carotid artery. Lines in yellow were used to determine arterial diameter and stretching before and following exercise.

News | Cardiac Diagnostics | July 16, 2018

July 16, 2018 — New research published in...

IVUS Demonstrates Greater Visualization of Dissections in iDissection Classification Study
News | Intra-Vascular Ultrasound (IVUS) | July 12, 2018

July 12, 2018 — Intact Vascular Inc. announced the publication of the iDissection Classification trial results in...

The Zoll LifeVest wearable defibrillator was the subject of the VEST Trial

The Zoll LifeVest wearable defibrillator system was evaluated in the late-breaking VEST Trial presented at ACC 2018 earlier this year.

Feature | Defibrillator Monitors | July 10, 2018 | Michael J. Mirro, M.D.

Following the...

PQ Bypass Effective in Treating Extremely Long SFA Lesions at 12 Months
News | Peripheral Artery Disease (PAD) | July 02, 2018

July 2, 2018 — The PQ Bypass Detour System showed promising 12-month durability for patients with extremely long...

New Tool Predicts Benefits and Risks of Implantable Defibrillator for Heart Failure Patients
News | Implantable Cardioverter Defibrillator (ICD) | July 02, 2018

July 2, 2018 — University of Washington (UW) Medicine cardiologists have developed a tool to predict which...

Xarelto Associated With Reduced Hospital Time and Costs for Low-risk PE Patients
News | Pulmonary Embolism | June 29, 2018

June 29, 2018 — Results from the MERCURY PE...

Watchman FLX in Clinical Trial at MedStar Heart and Vascular Institute
News | Left Atrial Appendage (LAA) Occluders | June 26, 2018

June 26, 2018 — MedStar Heart & Vascular Institute physicians participating in a...

New Target for Treating Heart Failure Identified by Penn Medicine Researchers

Microtubules in heart cells from a healthy patient (left) and from a patient with heart failure. The dense network of detyrosinated microtubules impedes the motion of the failing heart cell during the heart beat. Credit: Ben Prosser lab, Perelman School of Medicine, University of Pennsylvania

News | Heart Failure | June 25, 2018

June 25, 2018 — New research finds changes in cellular struts called microtubules (MT) can affect the stiffness of...

William O'Neill, M.D., unveils the Detroit Cardiogenic Shock Initiative at Henry Ford Hospital. The program uses new protocols to reduce cardiogenic shock mortality by 50 percent by using early hemodyanmic support.

William O'Neill, M.D., unveils the Detroit Cardiogenic Shock Initiative at Henry Ford Hospital. The program uses new protocols to reduce cardiogenic shock mortality by 50 percent by using early hemodyanmic support. 

Feature | Hemodynamic Support Devices | June 22, 2018 | Dave Fornell, Editor

About 50 percent of patients in cardiogenic shock do not survive, and account for about 90,000 heart attack patients...

Overlay Init